Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Retained Earnings: 2018

Historic Retained Earnings for DiaMedica Therapeutics (DMAC) over the last 1 years, with Dec 2018 value amounting to -$46.0 million.

  • DiaMedica Therapeutics' Retained Earnings was N/A to -$54.1 million in Q3 2019 from the same period last year, while for Sep 2019 it was -$54.1 million, marking a year-over-year change of. This contributed to the annual value of -$46.0 million for FY2018, which is N/A change from last year.
  • DiaMedica Therapeutics' Retained Earnings amounted to -$46.0 million in FY2018.
  • DiaMedica Therapeutics' Retained Earnings' 5-year high stood at -$46.0 million during FY2018, with a 5-year trough of -$46.0 million in FY2018.
  • In the last 1 years, DiaMedica Therapeutics' Retained Earnings had a median value of -$46.0 million in 2018 and averaged -$46.0 million.